Erick Wayne DeVinney, VP, Clinical&Translational Sc at Axogen, Inc. (AXGN), sold 371 shares at $17.81 ($7K) on 2020-12-29, disclosed to the SEC on 2020-12-30.
Open-market sale of $7k AXGN by VP, Clinical&Translational Sc. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| AXGN | SELL | 2025-09-16 | $19K | — | Filing → |
| AXGN | SELL | 2025-03-19 | $529K | — | Filing → |
| AXGN | SELL | 2024-03-25 | $35K | — | Filing → |